While it does carry the risk of sounding arrogant, it’s well-recognized truth that human beings have no one but themselves to thank for a world that’s efficient and inclusive at the same time. The transformative character of humans has lead to the formation of a spectrum that offers a much more refined way of doing things, thus leaving out tons of space for innovation meshed with basic human curiosity. Even though it does sound like a typical success story, in all honesty, it has been a risky business. The things human beings were tinkering with had no precedent and could have easily fallen apart, and some of them did as well, but the positives that came out of it made it seem like a worthwhile process. These positives, like their creators, were wholly transformative. Staying true to their nature, they have changed the landscape of our lives. All of a sudden, a piece of wild imagination was becoming a norm, and instead of being satisfied with that, bigger things were pushed into the pipeline.
Before we knew, we were living a completely different life, a life that was better and brought with it infinite bags of potential. Today we have tools that can be utilized to expand our horizons as individuals and as a society. The technological element of these tools adds a level of reliability to our growth, and there are few better examples for it than the medical field.
Medical sphere has been coming up with all sorts of creations to enhance human healthcare, and their latest attempt can be observed in a remote monitoring system for peritoneal dialysis. CloudCath, a San Francisco-based medtech company, has devised a remote monitoring device that delivers data regarding dialysate fluid management for at-home patients. The device gets easily integrated into the primary peritoneal dialysis systems, and from there it transmits the data to the cloud with proprietary algorithms. This method proves to be really helpful in terms of providing a timely indication of any major issues such as infections.
The traditional assessment methods for peritoneal dialysis have long been criticized for being lengthy and inept. CloudCath’s fresh piece of innovation is out to change that. The company has partnered with American Renal Associates, an outpatient dialysis provider, to conduct pre-market trials in the upcoming days.
